Oric Pharmaceuticals, Inc. short interest in 2025
In 2025, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 14.90% of shares outstanding on 15 Jan 2025 to 22.05% on 31 Dec 2025, a change of +7.15 percentage points. The year's high was 22.05% on 31 Dec 2025 and its low 7.42% on 15 Aug 2025, averaging 15.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.07 days on 14 Mar 2025. Full history: Oric Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 14.90% (15 Jan 2025)
- End of year
- 22.05% (31 Dec 2025)
- Change
- +7.15 pp
- High
- 22.05% (31 Dec 2025)
- Low
- 7.42% (15 Aug 2025)
- Average
- 15.85%
- Highest days to cover
- 28.07 (14 Mar 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 14.90% | 12.69 | |
| 31 Jan 2025 | 14.81% | 14.86 | |
| 14 Feb 2025 | 16.95% | 5.66 | |
| 28 Feb 2025 | 19.06% | 11.75 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 19.67% | 28.07 | |
| 31 Mar 2025 | 21.26% | 16.14 | |
| 15 Apr 2025 | 18.66% | 14.08 | |
| 30 Apr 2025 | 15.74% | 19.75 | |
| 15 May 2025 | 16.44% | 19.96 | 10-Q filed, results (8-K) |
| 30 May 2025 | 18.78% | 5.10 | |
| 13 Jun 2025 | 17.88% | 9.29 | |
| 30 Jun 2025 | 17.70% | 10.32 | |
| 15 Jul 2025 | 17.29% | 19.52 | |
| 31 Jul 2025 | 9.51% | 4.31 | |
| 15 Aug 2025 | 7.42% | 9.33 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 8.42% | 11.23 | |
| 15 Sep 2025 | 9.81% | 8.77 | |
| 30 Sep 2025 | 11.58% | 6.85 | |
| 15 Oct 2025 | 13.41% | 7.55 | |
| 31 Oct 2025 | 15.95% | 13.25 | |
| 14 Nov 2025 | 16.69% | 15.17 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 18.04% | 14.00 | |
| 15 Dec 2025 | 18.44% | 13.56 | |
| 31 Dec 2025 | 22.05% | 14.20 |
See also: Oric Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.